A U.S. Senate committee has scheduled a hearing for next week on a bipartisan bill to promote research into the therapeutic potential psychedelics by creating a new office in the Department of Veterans Affairs (VA) that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA.
The legislation—titled the Veterans Health Administration Novel Therapeutics Preparedness Act—is being led by Sen. Tim Sheehy (R-MT) and is cosponsored by Sens. Tammy Duckworth (D-IL), Ruben Gallego (D-AZ) and John Boozman (R-AR).
The Senate Veterans’ Affairs Committee will take up the psychedelics bill, along with 24 other pieces of legislation, on Wednesday.
Sheehy said when introducing the bill last month that it will “help the hardworking men and women at the VA fulfill” their “critical mission” of caring for veterans.
The planned hearing on the measure was first reported ahead of its official announcement by journalist Jack Gorsline of Psychedelic State(s) of America.
News: the first psychedelics-related congressional hearing this term has been scheduled.
A hearing in front of the Senate Veteran Affairs Committee (SVAC) for the “Veterans Health Administration Novel Therapeutics Preparedness Act” has been penciled in
Read full article on Marijuana Moment
